查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1957523

2026年全球维生素C市场报告

Obeticholic Acid Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，奥贝胆酸市场发展迅速。预计该市场将从2025年的10.1亿美元成长到2026年的11.4亿美元，复合年增长率（CAGR）为12.9%。过去几年的成长主要归功于以下几个方面：用于治疗原发性胆汁性胆管炎的临床核准、肝病诊断率的提高、肝病专科诊所的扩张、人们对胆汁酸调节疗法的认识不断提高以及肝病专科药物的增多。

预计未来几年奥贝胆酸市场将快速成长，到2030年将达到18.4亿美元，复合年增长率（CAGR）为12.7%。预测期内的成长要素包括非酒精性脂肪性肝炎（NASH）患者数量的增加、肝病治疗产品线的扩展、诊断筛检的进步、肝病研究投入的增加以及口服肝病疗法在全球范围内的普及。预测期内的主要趋势包括慢性肝病盛行率的上升、FXR促效剂疗法的广泛应用、对缓解疾病肝病疗法的日益关注、非酒精性脂肪性肝炎（NASH）研究的扩展以及口服肝病疗法的增加。

预计未来几年，肝病发生率的上升将推动奥贝胆酸需求的成长。肝病是一组损害肝臟正常功能的疾病。肝病发生率的上升主要归因于过量饮酒，过量饮酒会损害肝细胞并导致器官功能障碍，进而可能引发肝炎、肝硬化和肝功能衰竭。奥贝胆酸透过活化法尼醇X受体（FXR）来帮助肝病患者。 FXR能够抑制胆汁酸的积累，减轻肝臟炎症，延缓纤维化的进展，最终改善肝功能。例如，根据英国政府机构「健康改善与不平等」（Health Improvement and Inequality）于2024年12月发布的报告，2023年因酒精性肝病导致的过早死亡人数增加了3.6%，达到5984人（2022年为5776人）。因此，肝病盛行率的上升正在推动奥贝胆酸市场的扩张。

在奥贝胆酸领域主要企业正致力于开发创新治疗方法，例如法尼醇X受体（FXR）促效剂，以加强肝病管理并改善患者预后。法尼醇X受体（FXR）促效剂是能够刺激FXR的化合物，FXR是一种核受体，在调节肝臟胆汁酸代谢、发炎和纤维化方面发挥关键作用。 FXR促效剂有助于改善肝功能，并用于治疗原发性胆汁性胆管炎（PBC）和非酒精性脂肪性肝炎（NASH）。例如，2024年2月，总部位于美国的生物製药公司Intercept Pharmaceuticals宣布，美国食品药物管理局（FDA）已接受其用于治疗原发性胆汁性胆管炎（PBC）的药物Ocaliva的补充新药申请（sNDA）。 FDA 接受奥贝胆酸（Ocaliva）的补充新药申请（sNDA）代表监管方面的重大进展，证实了其在治疗原发性胆汁性胆管炎（PBC）方面的临床疗效。

目录

第一章：执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球维生素C酸市场：吸引力评分与分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 生物技术、基因组学和精准医疗
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 永续性、气候技术、循环经济
    • 人工智慧（AI）和自主人工智慧
  • 主要趋势
    • 慢性肝病盛行率不断上升
    • FXR促效剂疗法的扩展
    • 人们越来越关注缓解疾病肝臟疗法
    • 非酒精性脂肪性肝炎（NASH）研究的扩展
    • 口服肝臟治疗药物使用增加

第五章 终端用户产业市场分析

  • 肝病专科医院
  • 肝病专科诊所
  • 三级医疗医院
  • 胃肠病中心
  • 专科药房

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球维生素C市场：PESTEL分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球奥贝胆酸市场规模、对比及成长率分析
  • 全球维生素C市场表现：规模与成长，2020-2025年
  • 全球维生素C市场预测：规模与成长，2025-2030年，2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 依产品类型
  • 速释片、缓释片、薄膜衣片
  • 透过分销管道
  • 医院药局、零售药局、网路药局
  • 透过使用
  • 原发性胆汁性肝炎、非酒精性脂肪性肝炎及其他适应症
  • 依类型细分：速释片
  • 标准口服片剂，低剂量片剂
  • 按类型细分：缓释片
  • 徐放锭、1日1回投与用最适放出锭
  • 按类型细分：膜衣锭
  • 掩味片，肠溶片

第十章 区域与国别分析

  • 全球维生素C市场：依地区划分，历史资料及预测（2020-2025年、2025-2030年、2035年）
  • 全球维生素C市场：依国家划分，历史资料及预测（2020-2025年、2025-2030年、2035年）

第十一章 亚太市场

第十二章：中国市场

第十三章：印度市场

第十四章：日本市场

第十五章：澳洲市场

第十六章：印尼市场

第十七章：韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章：德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章：东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第三十章：加拿大市场

第31章：南美市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第三十五章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 维生素C市场：竞争格局及市场份额，2024年
  • 维生素C市场：公司估值矩阵
  • 维生素C市场：公司概况
    • Intercept Pharmaceuticals Inc.
    • Genfit
    • Gilead Sciences Inc.
    • Pfizer Inc.
    • Bayer AG

第37章 其他大型企业和创新企业

  • Sumitomo Dainippon Pharma Co. Ltd., Horizon Therapeutics, Alembic Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Lupin Limited, Zydus Cadila, Teva Pharmaceutical Industries Ltd., WuXi AppTec, Viva Life Sciences, Omgene Life Sciences Pvt. Ltd., Enanta Pharmaceuticals, Novo Nordisk A/S, AstraZeneca plc, Roche Holding AG, Sanofi SA

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年维生素C市场：提供新机会的国家
  • 2030年维生素C市场：提供新机会的市场
  • 2030年维生素C市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第41章附录

简介目录
Product Code: PH5MOACI03_G26Q1

Obeticholic acid is a drug mainly prescribed for managing liver conditions, particularly in patients with primary biliary cholangitis (PBC), a long-term liver disorder. It is a synthetic bile acid that functions by stimulating a receptor known as the farnesoid X receptor (FXR), which aids in controlling bile acid synthesis, supporting liver function, and reducing inflammation.

The primary product forms of obeticholic acid include tablets, capsules, and other variants. Tablets are solid dosage forms intended for easy oral administration. The drug is distributed through multiple channels such as hospital pharmacies, retail pharmacies, and online pharmacies. It is used to manage nonalcoholic steatohepatitis, primary biliary cholangitis, and other related conditions.

Tariffs have affected the obeticholic acid market by increasing the cost of imported active pharmaceutical ingredients, intermediates, and excipients used in bile acid-based therapies. These impacts have been most pronounced in specialty liver drug segments, particularly in north america and europe. Asia-pacific manufacturers have faced procurement delays and cost pressures. However, tariffs have supported localized API production and formulation, improving supply continuity.

The obeticholic acid market research report is one of a series of new reports from The Business Research Company that provides obeticholic acid market statistics, including obeticholic acid industry global market size, regional shares, competitors with a obeticholic acid market share, detailed obeticholic acid market segments, market trends and opportunities, and any further data you may need to thrive in the obeticholic acid industry. This obeticholic acid market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The obeticholic acid market size has grown rapidly in recent years. It will grow from $1.01 billion in 2025 to $1.14 billion in 2026 at a compound annual growth rate (CAGR) of 12.9%. The growth in the historic period can be attributed to clinical approval for primary biliary cholangitis treatment, rising liver disease diagnosis, expansion of hepatology clinics, increased awareness of bile acid regulation therapies, growth in specialty liver drugs.

The obeticholic acid market size is expected to see rapid growth in the next few years. It will grow to $1.84 billion in 2030 at a compound annual growth rate (CAGR) of 12.7%. The growth in the forecast period can be attributed to increasing NASH patient population, expansion of liver disease drug pipelines, improved diagnostic screening adoption, rising investment in hepatology research, global expansion of oral liver therapies. Major trends in the forecast period include rising prevalence of chronic liver diseases, increasing adoption of FXR agonist therapies, growing focus on disease-modifying liver drugs, expansion of nonalcoholic steatohepatitis research, increasing use of oral hepatology treatments.

The increasing incidence of liver diseases is expected to drive the demand for obeticholic acid in the coming years. Liver diseases are disorders that impair the liver's normal functioning. This rise in liver diseases is primarily attributed to excessive alcohol consumption, which can cause liver inflammation, cirrhosis, and liver failure by damaging liver cells and reducing the organ's ability to operate effectively. Obeticholic acid aids patients with liver diseases by activating the farnesoid X receptor (FXR), which lowers bile acid accumulation, diminishes liver inflammation, and slows the progression of fibrosis, ultimately enhancing liver function. For example, in December 2024, the Office for Health Improvement and Disparities, a UK government department, reported that premature deaths from alcoholic liver disease rose by 3.6% in 2023, reaching 5,984, up from 5,776 in 2022. Consequently, the growing prevalence of liver diseases is contributing to the expansion of the obeticholic acid market.

Major companies operating in the obeticholic acid sector are focusing on developing innovative therapies, such as farnesoid X receptor (FXR) agonists, to enhance liver disease management and improve patient outcomes. A farnesoid X receptor (FXR) agonist is a compound that stimulates the FXR, a nuclear receptor that plays a key role in regulating bile acid metabolism, inflammation, and fibrosis in the liver. Farnesoid X receptor (FXR) agonists aid in improving liver function and are utilized in treating conditions like primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). For example, in February 2024, Intercept Pharmaceuticals Inc., a US-based biopharmaceutical firm, announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) for Ocaliva to treat patients with primary biliary cholangitis (PBC). The FDA's acceptance of the supplemental New Drug Application (sNDA) for obeticholic acid (Ocaliva) represents a regulatory milestone toward confirming its clinical benefits in managing PBC.

In November 2023, Alfasigma, a pharmaceutical company based in Italy, acquired Intercept Pharmaceuticals, Inc. for USD 19.00 per share in cash. Through this acquisition, Alfasigma seeks to enhance its presence in the U.S. and broaden its portfolio in gastroenterology and hepatology. Intercept Pharmaceuticals, Inc. is a U.S.-based biopharmaceutical company dedicated to developing therapies for rare and serious liver diseases, including primary biliary cholangitis (PBC), with its leading product being Ocaliva.

Major companies operating in the obeticholic acid market are Intercept Pharmaceuticals Inc., Genfit, Gilead Sciences Inc., Pfizer Inc., Bayer AG, Sumitomo Dainippon Pharma Co. Ltd., Horizon Therapeutics, Alembic Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Lupin Limited, Zydus Cadila, Teva Pharmaceutical Industries Ltd., WuXi AppTec, Viva Life Sciences, Omgene Life Sciences Pvt. Ltd., Enanta Pharmaceuticals, Novo Nordisk A/S, AstraZeneca plc, Roche Holding AG, Sanofi S.A.

North America was the largest region in the Obeticholic Acid market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the obeticholic acid market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the obeticholic acid market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The obeticholic acid market consists of sales of products including tablets, generic obeticholic acid, ocaliva support services, patient education kits, and obeticholic acid + ursodeoxycholic acid (UDCA). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Obeticholic Acid Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses obeticholic acid market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for obeticholic acid ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The obeticholic acid market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Immediate-Release Tablets; Modified-Release Tablets; Film-Coated Tablets
  • 2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies; Online Pharmacies
  • 3) By Application: Primary Biliary Cholangitis; Nonalcoholic Steatohepatitis; Other Applications
  • Subsegments:
  • 1) By Immediate-Release Tablets: Standard Oral Tablets; Low-Dose Strength Tablets
  • 2) By Modified-Release Tablets: Controlled Exposure Tablets; Once-Daily Optimized Release Tablets
  • 3) By Film-Coated Tablets: Taste-Masked Tablets; Gastrointestinal-Tolerant Tablets
  • Companies Mentioned: Intercept Pharmaceuticals Inc.; Genfit; Gilead Sciences Inc.; Pfizer Inc.; Bayer AG; Sumitomo Dainippon Pharma Co. Ltd.; Horizon Therapeutics; Alembic Pharmaceuticals Ltd.; Dr. Reddy's Laboratories Ltd.; Lupin Limited; Zydus Cadila; Teva Pharmaceutical Industries Ltd.; WuXi AppTec; Viva Life Sciences; Omgene Life Sciences Pvt. Ltd.; Enanta Pharmaceuticals; Novo Nordisk A/S; AstraZeneca plc; Roche Holding AG; Sanofi S.A.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Obeticholic Acid Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Obeticholic Acid Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Obeticholic Acid Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Obeticholic Acid Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Sustainability, Climate Tech & Circular Economy
    • 4.1.5 Artificial Intelligence & Autonomous Intelligence
  • 4.2. Major Trends
    • 4.2.1 Rising Prevalence Of Chronic Liver Diseases
    • 4.2.2 Increasing Adoption Of Fxr Agonist Therapies
    • 4.2.3 Growing Focus On Disease-Modifying Liver Drugs
    • 4.2.4 Expansion Of Nonalcoholic Steatohepatitis Research
    • 4.2.5 Increasing Use Of Oral Hepatology Treatments

5. Obeticholic Acid Market Analysis Of End Use Industries

  • 5.1 Hepatology Hospitals
  • 5.2 Specialty Liver Clinics
  • 5.3 Tertiary Care Hospitals
  • 5.4 Gastroenterology Centers
  • 5.5 Specialty Pharmacies

6. Obeticholic Acid Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Obeticholic Acid Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Obeticholic Acid PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Obeticholic Acid Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Obeticholic Acid Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Obeticholic Acid Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Obeticholic Acid Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Obeticholic Acid Market Segmentation

  • 9.1. Global Obeticholic Acid Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Immediate-Release Tablets, Modified-Release Tablets, Film-Coated Tablets
  • 9.2. Global Obeticholic Acid Market, Segmentation By Distribution Channel, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
  • 9.3. Global Obeticholic Acid Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Primary Biliary Cholangitis, Nonalcoholic Steatohepatitis, Other Applications
  • 9.4. Global Obeticholic Acid Market, Sub-Segmentation Of Immediate-Release Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Standard Oral Tablets, Low-Dose Strength Tablets
  • 9.5. Global Obeticholic Acid Market, Sub-Segmentation Of Modified-Release Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Controlled Exposure Tablets, Once-Daily Optimized Release Tablets
  • 9.6. Global Obeticholic Acid Market, Sub-Segmentation Of Film-Coated Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Taste-Masked Tablets, Gastrointestinal-Tolerant Tablets

10. Obeticholic Acid Market Regional And Country Analysis

  • 10.1. Global Obeticholic Acid Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Obeticholic Acid Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Obeticholic Acid Market

  • 11.1. Asia-Pacific Obeticholic Acid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Obeticholic Acid Market

  • 12.1. China Obeticholic Acid Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Obeticholic Acid Market

  • 13.1. India Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Obeticholic Acid Market

  • 14.1. Japan Obeticholic Acid Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Obeticholic Acid Market

  • 15.1. Australia Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Obeticholic Acid Market

  • 16.1. Indonesia Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Obeticholic Acid Market

  • 17.1. South Korea Obeticholic Acid Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Obeticholic Acid Market

  • 18.1. Taiwan Obeticholic Acid Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Obeticholic Acid Market

  • 19.1. South East Asia Obeticholic Acid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Obeticholic Acid Market

  • 20.1. Western Europe Obeticholic Acid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Obeticholic Acid Market

  • 21.1. UK Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Obeticholic Acid Market

  • 22.1. Germany Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Obeticholic Acid Market

  • 23.1. France Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Obeticholic Acid Market

  • 24.1. Italy Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Obeticholic Acid Market

  • 25.1. Spain Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Obeticholic Acid Market

  • 26.1. Eastern Europe Obeticholic Acid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Obeticholic Acid Market

  • 27.1. Russia Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Obeticholic Acid Market

  • 28.1. North America Obeticholic Acid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Obeticholic Acid Market

  • 29.1. USA Obeticholic Acid Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Obeticholic Acid Market

  • 30.1. Canada Obeticholic Acid Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Obeticholic Acid Market

  • 31.1. South America Obeticholic Acid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Obeticholic Acid Market

  • 32.1. Brazil Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Obeticholic Acid Market

  • 33.1. Middle East Obeticholic Acid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Obeticholic Acid Market

  • 34.1. Africa Obeticholic Acid Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Obeticholic Acid Market, Segmentation By Product Type, Segmentation By Distribution Channel, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Obeticholic Acid Market Regulatory and Investment Landscape

36. Obeticholic Acid Market Competitive Landscape And Company Profiles

  • 36.1. Obeticholic Acid Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Obeticholic Acid Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Obeticholic Acid Market Company Profiles
    • 36.3.1. Intercept Pharmaceuticals Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Genfit Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Gilead Sciences Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Bayer AG Overview, Products and Services, Strategy and Financial Analysis

37. Obeticholic Acid Market Other Major And Innovative Companies

  • Sumitomo Dainippon Pharma Co. Ltd., Horizon Therapeutics, Alembic Pharmaceuticals Ltd., Dr. Reddy's Laboratories Ltd., Lupin Limited, Zydus Cadila, Teva Pharmaceutical Industries Ltd., WuXi AppTec, Viva Life Sciences, Omgene Life Sciences Pvt. Ltd., Enanta Pharmaceuticals, Novo Nordisk A/S, AstraZeneca plc, Roche Holding AG, Sanofi S.A.

38. Global Obeticholic Acid Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Obeticholic Acid Market

40. Obeticholic Acid Market High Potential Countries, Segments and Strategies

  • 40.1 Obeticholic Acid Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Obeticholic Acid Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Obeticholic Acid Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer